Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Sparrow

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Alimentary Pharmacology & Therapeutics|February 28, 2017
Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's diseaseM G Ward, P A Thwaites, L Beswick, et al.
Alimentary Pharmacology & Therapeutics|February 23, 2018
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study)A B Friedman, S J Brown, P Bampton, et al.
Internal Medicine Journal|March 4, 2015
Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patientsS P Costello, S Ghaly, L Beswick, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|May 15, 2026
Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort StudyR Gilmore, T Pham, R G Fernandes, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Alimentary Pharmacology & Therapeutics|February 28, 2017
Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's diseaseM G Ward, P A Thwaites, L Beswick, et al.
Alimentary Pharmacology & Therapeutics|February 23, 2018
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study)A B Friedman, S J Brown, P Bampton, et al.
Internal Medicine Journal|March 4, 2015
Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patientsS P Costello, S Ghaly, L Beswick, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|May 15, 2026
Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort StudyR Gilmore, T Pham, R G Fernandes, et al.
Pageof 7